These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2328491

  • 21. Dual mechanisms of inhibition of DNA synthesis by triciribine.
    Wotring LL, Townsend LB, Jones LM, Borysko KZ, Gildersleeve DL, Parker WB.
    Cancer Res; 1990 Aug 15; 50(16):4891-9. PubMed ID: 2379153
    [Abstract] [Full Text] [Related]

  • 22. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
    Abdel-Aziz W, Jiang HY, Hickey RJ, Malkas LH.
    Cancer Chemother Pharmacol; 2000 Aug 15; 45(4):312-9. PubMed ID: 10755320
    [Abstract] [Full Text] [Related]

  • 23. Detection of 1-beta-D-arabinofuranosylcytosine incorporation into DNA in vivo.
    Spriggs D, Robbins G, Ohno Y, Kufe D.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6532-6. PubMed ID: 3479246
    [Abstract] [Full Text] [Related]

  • 24. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD, Joneckis CC, Song TH, Wu RK.
    Cancer Res; 1988 Feb 01; 48(3):517-21. PubMed ID: 3335018
    [Abstract] [Full Text] [Related]

  • 25. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC, Hutchinson DJ, Schmid FA, Philips FS.
    Cancer Res; 1975 Jan 01; 35(1):225-36. PubMed ID: 1109791
    [Abstract] [Full Text] [Related]

  • 26. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Jan 01; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 27. Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine.
    Woodcock DM, Fox RM, Cooper IA.
    Cancer Res; 1979 Apr 01; 39(4):1418-24. PubMed ID: 421225
    [Abstract] [Full Text] [Related]

  • 28. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ.
    Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322
    [Abstract] [Full Text] [Related]

  • 29. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 01; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of DNA synthesis by 1-beta-D-arabinofuranosylcytosine.
    Bremerskov V.
    Biomedicine; 1975 May 01; 22(3):217-22. PubMed ID: 1174630
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 01; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 32. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H, Drewinko B.
    Cancer Res; 1986 Mar 01; 46(3):1105-9. PubMed ID: 3080232
    [Abstract] [Full Text] [Related]

  • 33. Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms.
    Lacombe F, Belloc F, Dumain P, Puntous M, Lopez F, Bernard P, Boisseau MR, Reiffers J.
    Cytometry; 1992 Mar 01; 13(7):730-8. PubMed ID: 1451603
    [Abstract] [Full Text] [Related]

  • 34. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 01; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 35. 1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
    Myers-Robfogel MW, Spataro AC.
    Cancer Res; 1980 Jun 01; 40(6):1940-3. PubMed ID: 7371029
    [Abstract] [Full Text] [Related]

  • 36. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
    Gandhi V, Huang P, Chapman AJ, Chen F, Plunkett W.
    Clin Cancer Res; 1997 Aug 01; 3(8):1347-55. PubMed ID: 9815818
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 38. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.
    Ohno Y, Spriggs D, Matsukage A, Ohno T, Kufe D.
    Cancer Res; 1988 Mar 15; 48(6):1494-8. PubMed ID: 3345522
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Grem JL, Allegra CJ.
    Cancer Res; 1990 Nov 15; 50(22):7279-84. PubMed ID: 1699659
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of deoxyribonucleic acid chain initiation: a new mode of action for 1-beta-D-arabinofuranosylcytosine in human lymphoblasts.
    Fridland A.
    Biochemistry; 1977 Nov 29; 16(24):5308-12. PubMed ID: 921933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.